GenuScan helps pharmaceutical manufacturers protect patients, detect counterfeit drugs, and maintain visibility across increasingly complex global distribution networks. From Counterfeit medicines and devices to unauthorized distribution channels, pharmaceutical brands face risks that impact both patient safety and brand trust.
.png)
.png)
It introduces risks far beyond lost revenue. Fake, diverted, or improperly handled products can directly harm patients and damage brand credibility.
Key risks include:

Counterfeit medicines and devices entering legitimate supply chains

Diverted product entering unauthorized markets

Expired or mishandled products being resold

Lack of authentication tools outside regulated channels

Brand damage from safety incidents


Patient safety concerns

Supply chain integrity gaps

Compliance reporting pressure

Difficulty detecting counterfeits in secondary markets

Limited verification beyond regulated environments

Serialization limitations outside primary distribution
GenuScan complements pharmaceutical compliance systems by providing real-world product verification and distribution intelligence — bringing authentication into the field, where compliance frameworks alone don’t reach.
.png)
Provide verifiable, data-driven evidence.
.png)
Verify products anywhere using a smartphone.
.png)
Spot fake product activity in secondary markets.
.png)
Surface unauthorized distribution patterns.
.png)
Build a continuous picture of supply chain reality.
Discover how True Pedigree can help you identify counterfeits, stop diversion, and gain complete visibility into your global supply chain, without changing your manufacturing processes.

Copyright 2026 True Pedigree All rights reserved.